|
시장보고서
상품코드
1375079
유럽 약물전달 시장 예측(-2028년) : 지역별 분석 - 투여 경로, 유통 채널, 최종 사용자별Europe Drug Delivery Market Forecast to 2028- COVID-19 Impact and Regional Analysis- by Route of Administration, Distribution Channel, and End User |
||||||
유럽 약물전달 시장은 2023년 6,322억 6,846만 달러에서 2028년 8,953억 3,887만 달러로 성장할 것으로 예측됩니다. 2023년부터 2028년까지 CAGR은 7.2%로 추정됩니다.
비침습 약물전달 시스템에 대한 수요 증가가 유럽 약물전달 시장을 뒷받침
비침습 약물전달은 일반적으로 점막 표면 및 피부의 생물학적 장벽을 넘어 통증 없이 약물을 전달하는 방법을 말합니다. 이 약물전달은 의약품에 대한 액세스를 개선하고, 치료 정책의 준수를 향상시키고, 의약품의 안전성을 향상시킬 수 있습니다. 주사에 의한 약물 투여에 비해 이러한 명백한 이점이 있기 때문에 환자는 비침습적 약물전달 경로를 선호합니다. 비침습적인 방식으로 약물을 투여하면 치료 중 통증이 줄어들어 환자의 컴플라이언스가 매우 높아진다는 것을 알 수 있습니다. 의료기기 및 경피 전달 기술의 향상으로 비침습적인 약물전달 방법은 경구 및 주사를 통한 기존의 약물전달 방법과 경쟁할 준비가 되고 있습니다. 외용제, 경피 활성제(장치에 의한 침투 촉진), 경피 수동제, 경안막제, 경점막제, 흡입제의 폐포막을 통한 전달 등은 일반적으로 사용되는 비침습적 약물전달 법의 일부입니다.
낮은 거부율, 투여 용이성, 편의성, 내구성으로 인해 TDDS는 약물전달의 가장 매력적인 방법이 되었습니다. 의료 시설에서의 약물 투여 외에도 TDDS는 스킨케어 산업에서 다양한 치료에도 사용할 수 있습니다. 이 방법은 주로 국소 투여를 수행하므로 약물이 표적이 아닌 조직으로의 비특이적 전달을 예방할 수 있습니다. TDDS의 개발은 심혈관 및 중추 신경계 질환, 유전성 질환, 당뇨병, 신경근 질환, 감염증(국소를 포함한다)의 만연을 억제하는데 도움이 될 가능성이 높고, 동시에 백신 접종의 진보나, 장기 치료를 위한 약물의 자가 투여에 대한 환자의 선호를 촉진합니다.
비침습적 방법을 통한 약물전달은 투여 횟수를 줄이고 투여 일정을 간소화합니다. 또한, 이러한 전달 시스템은 환자가 이러한 방식으로 약물을 자체 투여할 수 있기 때문에 임상 사용 비용을 크게 줄일 수 있습니다. 종종 비침습적 전달 시스템을 이용한 약물 제조 비용은 주사 제조 비용보다 낮습니다. 예를 들어, 흡입 인슐린은 당뇨병 치료에 대한 내약성이 높고 선호되는 방법으로 등장했습니다. 이와 같이 비침습적 약물전달 시스템에 대한 수요 증가는 약물전달 시스템 시장의 성장을 뒷받침하고 있습니다.
유럽 약물전달 시장 개요
유럽 약물전달 시장은 독일, 프랑스, 이탈리아, 영국, 스페인 및 기타 유럽으로 세분화됩니다. 이 지역 시장 성장은 만성 질환 증가, 노인 인구 증가, 시장 진출기업의 확대 전략, 제약 산업의 성장과 관련이 있습니다. 독일은 기술의 진보로 알려져 있으며 의료 의료 분야의 최전선을 이끌고 있습니다. Haselmeier와 같은 독일 기업들은 D-Flex 펜을 개발했습니다. D-Flex 펜은 이전에 개발된 주사 펜보다 효율적으로 작동하는 약물전달 장치입니다. 이 펜은 피하 자가주사용 차세대 약물전달 장치입니다. 이 다중 용량 고정 펜은 단일 고정 용량 또는 미리 설정된 여러 용량으로 약물을 투여할 수 있기 때문에 기존의 약물전달 장치보다 선호됩니다.
유럽 약물전달 시장의 수익과 예측(-2028년)(100만 달러)
유럽 약물전달 시장 세분화
유럽 약물전달 시장은 투여 경로, 유통 채널, 최종 사용자, 국가별로 구분됩니다.
투여 경로에 따라, 유럽 약물전달 시장은 주사 약물전달, 경구 약물전달, 경점막 약물전달, 국소 약물전달, 이식 약물전달, 안약 전달로 구분됩니다. 2023년 유럽 약물전달 시장에서는 주사제 약물전달 분야가 큰 점유율을 차지하고 있습니다.
유통 채널에 따라 유럽 약국 전달 시장은 병원 약국, 소매 약국 및 온라인 약국으로 구분됩니다. 병원 약국 부문은 2023년 유럽 약물전달 시장에서 가장 큰 점유율을 차지했습니다.
최종 사용자별로 보면, 유럽 약물전달 시장은 병원 및 클리닉, 재택치료 현장, 기타 최종 사용자로 구분됩니다. 병원 및 클리닉 부문은 2023년 유럽 약국 전달 시장에서 가장 큰 점유율을 차지했습니다.
국가별로 유럽 약물전달 시장은 독일, 프랑스, 영국, 이탈리아, 스페인 및 기타 유럽으로 구분됩니다. 2023년 유럽 약물전달 시장에서 독일이 가장 큰 점유율을 차지했습니다.
Bausch Health Companies Inc, Baxter International Inc, Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Novo Nordisk AS, Pfizer 는 유럽 약물전달 시장에서 사업을 전개하는 주요 기업입니다.
목차
제1장 서론
제2장 유럽 약물전달 시장 - 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 유럽 약물전달 시장 상황
- 개관
- 유럽 PEST 분석
- 전문가의 견해
제5장 유럽 약물전달 시장 : 주요 시장 역학
- 시장 성장 촉진요인
- 만성 질환 증가
- 비침습 약물전달 시스템에 대한 수요 증가
- 제약회사의 연구개발비 증가
- 주요 시장 성장 억제요인
- 약물전달 개발에 따른 고비용
- 약물전달 제품 리콜
- 주요 시장 기회
- 환자의 컴플라이언스 향상에 주력
- 향후의 동향
- 전략적 개발과 제품상시
- 영향 분석
제6장 약물전달 시장 - 유럽 분석
- 유럽 약물전달 시장 수익과 예측 분석
제7장 유럽 약물전달 시장 : 2028년까지 수익과 예측 - 투여 경로별
- 소개
- 유럽 약물전달 시장의 투여 경로별 수익 점유율(2022년, 2028년)
- 주사 약물전달
- 경구 약물전달
- 국소 약물전달
- 경점막 약물전달
- 매립형 약물전달
- 안과용 약물전달
제8장 유럽 약물전달 시장 : 2028년까지 수익과 예측 - 유통 채널별
- 소개
- 유럽 약물전달 시장의 유통 채널별 수익 점유율(2022년, 2028년)
- 병원 약국
- 소매 약국
- 온라인 약국
제9장 유럽 약물전달 시장 : 2028년까지 수익과 예측 - 최종 사용자별
- 소개
- 유럽 약물전달 시장 최종 사용자별 매출 점유율(2022년, 2028년)
- 병원 및 클리닉
- 재택치료의 현장
- 기타 최종 사용자
제10장 유럽 약물전달 시장 : 2028년까지 수익과 예측 - 국가별 분석
- 영국
- 독일
- 프랑스
- 스페인
- 이탈리아
- 기타 유럽
제11장 유럽 약물전달 시장 : 업계 상황
- 소개
- 유럽 약물전달 시장의 성장 전략
- 유기적 성장 전략
- 개요
- 무기적 성장 전략
- 개요
제12장 기업 프로파일
- Becton Dickinson and Co
- Novo Nordisk AS
- Boston Scientific Corp
- Baxter International Inc
- Gerresheimer AG
- GlaxoSmithKline Plc
- Bausch Health Companies Inc
- Boehringer Ingelheim International GmbH
- Novartis AG
- Sever Pharma Solutions
- Johnson & Johnson
- Pfizer Inc
제13장 부록
JHS 23.11.17The Europe drug delivery market is expected to grow from US$ 6,32,268.46 million in 2023 to US$ 8,95,338.87 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2023 to 2028.
Growing Demand for Noninvasive Drug Delivery Systems Fuel Europe Drug Delivery Market
Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.
A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.
Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.
Europe Drug Delivery Market Overview
The Europe drug delivery market is sub segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth in this region is associated with rise in incidences of chronic diseases, increase in the geriatric population, expansion strategies by the market players, and growth of the pharmaceutical industry. Germany is known for its technological advancements, leading the country to the forefront in the medical & healthcare sectors. German companies such as Haselmeier have developed the D-Flex pen, a drug delivery device that works more efficiently than previously developed injection pens. The pen is the next-generation drug delivery device for subcutaneous self-injection. The multi-dose fixed pen can administer the drug in a single fixed dose or several pre-set doses; therefore, it is preferred over conventional drug delivery devices.
Europe Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)
Europe Drug Delivery Market Segmentation
The Europe drug delivery market is segmented into route of administration, distribution channel, end user, and country.
Based on route of administration, the Europe drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Europe drug delivery market in 2023.
Based on distribution channel, the Europe drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Europe drug delivery market in 2023.
Based on end user, the Europe drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the Europe drug delivery market in 2023.
Based on country, the Europe drug delivery market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe drug delivery market in 2023.
Bausch Health Companies Inc; Baxter International Inc; Becton Dickinson and Co; Boehringer Ingelheim International GmbH; Boston Scientific Corp; Gerresheimer AG; GlaxoSmithKline Plc; Johnson & Johnson; Novartis AG; Novo Nordisk AS; Pfizer Inc; and Sever Pharma Solutions are the leading companies operating in the Europe drug delivery market.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe drug delivery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Europe drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table Of Contents
1. Introduction
- 1.1 Study Scope
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Europe Drug Delivery Market - by Route of Administration
- 1.3.2 Europe Drug Delivery Market - by Distribution Channel
- 1.3.3 Europe Drug Delivery Market - by End User
- 1.3.4 Europe Drug Delivery Market - by Country
2. Europe Drug Delivery Market - Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Drug Delivery Market - Market Landscape
- 4.1 Overview
- 4.2 Europe PEST Analysis
- 4.3 Expert's Opinion
5. Europe Drug Delivery Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Incidence of Chronic Diseases
- 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
- 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
- 5.2 Key Market Restraints
- 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
- 5.2.2 Product Recalls in Drug Delivery Systems
- 5.3 Key Market Opportunities
- 5.3.1 Focus on Improving Patient Compliance
- 5.4 Future Trends
- 5.4.1 Strategic Developments and Product Launches
- 5.5 Impact analysis
6. Drug Delivery Market -Europe Analysis
- 6.1 Europe Drug Delivery Market Revenue Forecast and Analysis
7. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration
- 7.1 Overview
- 7.2 Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
- 7.3 Injectable Drug Delivery
- 7.3.1 Overview
- 7.3.2 Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.2.1 Conventional Injection Devices
- 7.3.2.1.1 Overview
- 7.3.2.1.2 Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.2.2 Advanced Devices
- 7.3.2.2.1 Overview
- 7.3.2.2.2 Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.2.1 Conventional Injection Devices
- 7.4 Oral Drug Delivery
- 7.4.1 Overview
- 7.4.2 Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.2.1 Solid Oral Drugs
- 7.4.2.1.1 Overview
- 7.4.2.1.2 Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.2.2 Liquid Oral Drugs
- 7.4.2.2.1 Overview
- 7.4.2.2.2 Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.2.3 Semi-solid Oral Drugs
- 7.4.2.3.1 Overview
- 7.4.2.3.2 Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4.2.1 Solid Oral Drugs
- 7.5 Topical Drug Delivery
- 7.5.1 Overview
- 7.5.2 Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.2.1 Semi-solid Topical Drug Delivery
- 7.5.2.1.1 Overview
- 7.5.2.1.2 Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.2.2 Liquid Topical Drug Delivery Formulations
- 7.5.2.2.1 Overview
- 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.2.3 Solid Topical Drug Delivery Formulations
- 7.5.2.3.1 Overview
- 7.5.2.3.2 Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.2.4 Transdermal
- 7.5.2.4.1 Overview
- 7.5.2.4.2 Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.5.2.1 Semi-solid Topical Drug Delivery
- 7.6 Transmucosal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6.2.1 Pulmonary and Nasal Drug Delivery
- 7.6.2.1.1 Overview
- 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6.2.2 Buccal and Sublingual Drug Delivery
- 7.6.2.2.1 Overview
- 7.6.2.2.2 Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6.2.3 Rectal Transmucosal Drug Delivery
- 7.6.2.3.1 Overview
- 7.6.2.3.2 Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6.2.4 Vaginal Transmucosal Drug Delivery
- 7.6.2.4.1 Overview
- 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.6.2.1 Pulmonary and Nasal Drug Delivery
- 7.7 Implantable Drug Delivery
- 7.7.1 Overview
- 7.7.2 Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8 Ocular Drug Delivery
- 7.8.1 Overview
- 7.8.2 Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8.2.1 Eye Drops and Sprays
- 7.8.2.1.1 Overview
- 7.8.2.1.2 Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8.2.2 Gels and Ointments
- 7.8.2.2.1 Overview
- 7.8.2.2.2 Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8.2.3 Ocular Inserts and Punctal Plugs
- 7.8.2.3.1 Overview
- 7.8.2.3.2 Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8.2.4 Therapeutic Contact Lens
- 7.8.2.4.1 Overview
- 7.8.2.4.2 Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 7.8.2.1 Eye Drops and Sprays
8. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel
- 8.1 Overview
- 8.2 Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
- 8.3 Hospital Pharmacies
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Retail Pharmacies
- 8.4.1 Overview
- 8.4.2 Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
- 8.5 Online Pharmacies
- 8.5.1 Overview
- 8.5.2 Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By End User
- 9.1 Overview
- 9.2 Europe Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
- 9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Home Care Settings
- 9.4.1 Overview
- 9.4.2 Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
- 9.5 Other End User
- 9.5.1 Overview
- 9.5.2 Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
10. Europe Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis
- 10.1 Overview
- 10.1.1 Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
- 10.1.1.1 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 Overview
- 10.1.1.1.2 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.3 UK: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
- 10.1.1.1.3.1 UK: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.1.3.2 UK: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.1.3.3 UK: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.1.3.4 UK: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.1.3.5 UK: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.1.4 UK: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
- 10.1.1.1.5 UK: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
- 10.1.1.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.3 Germany: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
- 10.1.1.2.3.1 Germany: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.2.3.2 Germany: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.2.3.3 Germany: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.2.3.4 Germany: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.2.3.5 Germany: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.2.4 Germany: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
- 10.1.1.2.5 Germany: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
- 10.1.1.3 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Overview
- 10.1.1.3.2 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.3 France: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
- 10.1.1.3.3.1 France: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.3.3.2 France: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.3.3.3 France: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.3.3.4 France: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.3.3.5 France: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.3.4 France: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
- 10.1.1.3.5 France: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
- 10.1.1.4 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Overview
- 10.1.1.4.2 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.3 Spain: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
- 10.1.1.4.3.1 Spain: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.4.3.2 Spain: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.4.3.3 Spain: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.4.3.4 Spain: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.4.3.5 Spain: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.4.4 Spain: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
- 10.1.1.4.5 Spain: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
- 10.1.1.5 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Overview
- 10.1.1.5.2 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.3 Italy: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
- 10.1.1.5.3.1 Italy: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.5.3.2 Italy: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.5.3.3 Italy: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.5.3.4 Italy: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.5.3.5 Italy: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.5.4 Italy: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
- 10.1.1.5.5 Italy: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
- 10.1.1.6 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Overview
- 10.1.1.6.2 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.3 Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration, 2020-2028 (US$ Million)
- 10.1.1.6.3.1 Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.6.3.2 Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.6.3.3 Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.6.3.4 Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.6.3.5 Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
- 10.1.1.6.4 Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel, 2020-2028 (US$ Million)
- 10.1.1.6.5 Rest of Europe: Europe Drug Delivery Systems Market, by End User 2020-2028 (US$ Million)
- 10.1.1.1 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
- 10.1.1 Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
11. Europe Drug Delivery Market - Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in Europe Drug Delivery Market
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
- 11.4 Inorganic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Novo Nordisk AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Baxter International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Gerresheimer AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 GlaxoSmithKline Plc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.5.1 Key Developments
- 12.7 Bausch Health Companies Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Boehringer Ingelheim International GmbH
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Novartis AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Sever Pharma Solutions
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Johnson & Johnson
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
- 12.12 Pfizer Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
